Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and tolerability of QUTENZA ® (capsaicin) 8% topical system in post-surgical neuropathic ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Research Grid raises $6.48M to advance clinical trial automation. Discover how this funding will enhance efficiency and speed in medical research.

Medidata has debuted two new bundled services meant to speed up and support clinical trials in oncology and vaccines, the ...

Oct. 29, 2024 /PRNewswire/ -- Oracle Health Summit -- To help life sciences organizations accelerate and reduce the cost and complexity of clinical trials so they can get lifesaving treatments to ...

A nationwide clinical trial aimed at improving prostate cancer treatment has concluded, with The Clatterbridge Cancer Centre ...

PAR made substantial progress in its Phase 3 clinical trial preparations for the treatment of knee osteoarthritis (OA) with ...